laminin-5, and type VII collagen, revealed normal staining (data not shown). Immunofluorescence for type XVII collagen in the skin of the parents was normal in a continuous pattern.
Transmission electron microscopy of the proband's fragile skin, after gentle rubbing, revealed the plane of cleavage within the lamina lucida. Perilesional skin from the affected area demonstrated the presence of a reduced number of hypoplastic hemidesmosomes, whereas in the samples of clinically unaffected skin, basal cells with normal appearing hemidesmosomes were seen adjacent to those with hypoplastic hemidesmosomes.
Essentially, all (98%-100%) of cultured keratinocytes was approximated 50%. Therefore, the type XVII collagen-positive keratinocytes apparently had a selective growth advantage in vitro. These cells were isolated by ( Figure 1 ). These patches covered about 10% of the a fluorescence-activated cell sorter (FACS) for subsetotal body surface area. In these clinically unaffected quent DNA studies. The type XVII collagen-negative mosaic skin patches, we could not evoke blisters, cells, Ͻ2% of the cultured keratinocytes, were too few whereas the complementary skin showed blisters after in number to allow their isolation by FACS, since this gentle rubbing. Some of the clinically unaffected skin fraction was contaminated by type XVII collagen-posipatches were new and expanded slowly with the years, tive keratinocytes. We therefore excluded the type XVII while other patches had been present as long as she collagen-negative cell fraction derived from clinically can remember and remained stationary. unaffected skin for further genetic studies, and used Immunofluorescence staining with monoclonal antithe unsorted type XVII collagen-negative keratinocytes bodies (1D1, 1A8c) against type XVII collagen was negaderived from clinically affected skin for comparison. tive in biopsy specimens of the clinically affected skin.
Gross chromosomal aberrations were not detected by Surprisingly, however, in the clinically unaffected mokaryotyping of the proband's fibroblasts (data not saic patches type XVII collagen was present in approxishown). mately 50% of the basal cells, although in a slightly reduced intensity. The positive cells were in groups of about 10-50 adjacent cells (Figure 2 ). Staining for anIdentification of the Paternal COL17A1 Mutation other hemidesmosomal adhesion molecule ␣6␤4 inteWe concluded that the gene for type XVII collagen, grin showed a normal continuous pattern at the dermal-COL17A1, may be the candidate gene for mutations in epidermal junction by dual fluorescence microscopy this patient. Consequently, we scanned COL17A1 for (Figure 2) . Similarly, other basement membrane zone putative pathogenetic mutations using the strategy components, including plectin/HD-1, BPAG1, laminin-1, based on PCR amplification of genomic DNA followed by heteroduplex analysis. In case of evidence for a sequence variant, i.e., the presence of a heteroduplex, the PCR product was subjected to direct automated sequencing. Utilizing this strategy, we found a heteroduplex in the proband's and father's PCR product corresponding to exon 51 sequence within COL17A1 ( Figure  3A ). Direct sequencing of the PCR product revealed a nonsense mutation at nt 3781 ( Figure 3B ). Restriction enzyme analysis revealed that the paternal mutation remained present in all DNA samples of the proband (Figure 3C ). The paternal mutation was therefore not involved in the mosaicism. frameshift and a premature termination codon 54 bp maternal allele in DNA from proband's WT/R1226X keratinocytes ( Figure 6 ). This discovery makes back mutadownstream from the deletion. This maternal mutation tion by insertion of the deleted single nucleotide A unwas not present in type XVII collagen-positive keratinolikely, since the reverse mutation involved both the cytes from the clinically unaffected skin of the proband, maternal mutation and the neighboring intragenic microin contrast to the other cell samples of the proband, satellite. including fibroblasts cultured from the same skin biopsy A possible deletion in COL17A1 was excluded by sev-( Figure 4C ). eral observations. First, PCR amplification of genomic The revertant keratinocytes expressed type XVII colla-DNA segment spanning from intron 16 to intron 19 gen in reduced amounts at the protein level ( Figure 5 ).
showed only a single band (1892 bp) on agarose gel Thus, the proband was a compound heterozygote electrophoresis in all DNA samples of the proband, in-(COL17A1: 1706delA/R1226X) with a reverse mutation cluding leukocytes and fibroblasts, as well as 1706delA/ abolishing the maternal mutation in type XVII-positive R1226X and WT/R1226X keratinocytes (data not shown). keratinocytes (COL17A1: WT/R1226X).
Second, direct sequencing of these amplimers showed no nucleotide deletions, and the 1 bp polymorphism in intron 19 ( Figure 6 ) was still present heterozygously in The Molecular Mechanism of the Reverse Mutation Analysis of a microsatellite polymorphism within intron these PCR products. A deletion of exons 17, 18, and 19, which could shorten the protein by as much as 15 18 of COL17A1 located 381 bp downstream from the maternal mutation in exon 18 revealed a loss of the kDa, was therefore excluded. Third, a larger deletion Western blot of protein extracts of keratinocytes from clinically unaffected (lanes 1 and 4) and affected (lanes 2 and 5) skin of the proband, and from keratinocytes of a normal individual (lanes 3 and 6), using type XVII collagen monoclonal antibody (lanes 1-3) or serum from a patient with bullous pemphigoid (lanes 4-6). Proband's WT/R1226X keratinocytes show reduced level of normal length type XVII collagen protein of the approximate size of 180 kDa. Type XVII collagen is undetectable in 1706delA/R1226X keratinocytes. Note that a 120 kDa antigen, recognized by the bullous pemphigoid serum, is reduced in WT/R1226X keratinocytes and undetectable in 1706delA/R1226X keratinocytes.
was excluded by Western blot analysis, which revealed that keratinocytes from proband's clinically unaffected the reverse mutation. Thus, the conversion tract (segment of nonreciprocally exchanged DNA) spanned at least 381 bp exrecessive junctional epidermolysis bullosa causes retending from the maternal mutation in exon 18 to the version of the phenotype in a mosaic pattern. This findmicrosatellite in intron 18. This exchange may have been ing of a reverse mutation in human is remarkable, becaused by a double crossing-over during mitosis, which cause the genetic mechanism is demonstrated to be we considered very unlikely (cf. Discussion), or by a gene conversion. mitotic gene conversion. Due to the lack of observed heterozygosity within the sequences of introns 3 to 17, the major part of which has been sequenced, the length Molecular Mechanisms of Reverse of the conversion tract of DNA cannot be determined Mutation in Somatic Mosaicism with more accuracy, because loss or retension of heteroSomatic mosaicism mostly refers to clinically altered zygosity cannot be analyzed. Sequencing of additional patches of tissue as a result of deleterious effects of a upstream intronic sequences is currently in progress.
gross chromosomal abnormality or a single gene mutation (Hall, 1988) . In the event of mutation during mitosis of somatic cells that originate from a single zygote, two Discussion or more genetically different populations of cells will develop. After somatic mutation, the mosaic tissue conThis study presents evidence that mitotic gene convertains mutant cells that stand out against the background sion of one parental mutation in the COL17A1 gene of wild-type cells. Clinically, this may result in tumorigenesis (Cavenee et al., 1983) or, in the skin, lead to nevi of a compound heterozygote proband with autosomal Homologous chromosomes carry the paternal (blue) or maternal (pink) mutation. In each situation, loss of heterozygosity-homozygosity or hemizygosity-is reached along the altered tract. Cells devoid of the protein are depicted white and cells with a revertant phenotype are depicted green; solid for producing functional protein, and hatched for producing semi-functional protein. Note that gene conversion and double crossing-over may result in the same revertant genotype; however, in the latter the revertant cells may theoretically be accompanied by unique sister cells. It can be anticipated that these cells will disappear due to selective disadvantage. (Happle, 1993; Paller et al., 1994) . Since this phenomewere homozygous for a frameshift mutation (4003delTC) in exon 52 of COL17A1 (McGrath et al., 1996) . In contrast non changes the phenotype from wild-type to a mutant phenotype, we call this "forward mosaicism."
to our patient, their patient had no patches of clinically unaffected skin. A possible explanation for this phenomSomatic mosaicism may also develop after somatic reverse mutation, i.e., the spontaneous correction of a enon might be mitotic gene deletion that restores the reading frame in one of the two alleles or alternative deleterious mutation during mitosis. The mosaic tissue then contains revertant cells that stand out against the splicing with inframe skipping of the mutation. Either way, the result is a shortened semifunctional protein with background of mutant cells. This condition can be designated "revertant mosaicism," as opposed to forward recovered immunohistochemical staining properties in a mosaic pattern (Figure 7 ). mosaicism. In revertant mosaicism, but not in forward mosaicism, the parents carry the mutation.
The selective advantage of type XVII collagen-positive keratinocytes was more pronounced in vitro than in vivo The mechanisms involved in somatic mutation are characterized by loss of heterozygosity (Cavenee et al., in our proband: the amount of revertant keratinocytes in culture was more than 98% of the total population, 1983). Somatic cells become either homozygous at a certain locus during mitotic recombination, resulting whereas this percentage did not reach beyond 50% in the revertant skin patches. Only the appearance of new from a (double) crossing-over, gene conversion, or reverse point (back) mutation, or hemizygous resulting patches later in life and their slow expansion would indicate that the selective advantage of revertant kerafrom a nondisjunction or deletion (Figure 7) . tinocytes did also happen in vivo. The type XVII collagenpositive keratinocytes are probably monoclonal, derived Micromosaicism within Revertant Skin Examination of the clinically unaffected skin patches of from a single revertant progenitor cell, whereas the negative keratinocytes are possibly polyclonal and may dethe proband revealed that approximately 50% of the basal cells expressed type XVII collagen in segments of rive from more than one mutant progenitor cell. It remains to be resolved why culture conditions increase 10-50 adjacent cells by immunofluorescence microscopy (Figure 2 ). These positive clusters may reflect the the selective disadvantage of mutant COL17A1 keratinocytes. presence of cells supplied by divisions of revertant stem cells. One of the patients of the original GABEB family Thus, at the cellular level, a micromosaicism could be observed, consisting of a mixture of revertant and described by Hinter and Wolf (1992) also had segments of linear type XVII collagen staining in the skin (Pohlamutant keratinocytes in the basal cell layer in the skin patches. If this phenomenon also applies to forward Gubo et al., 1995). The affected members of this family mosaicism, one may expect wild-type keratinocytes in reversion has also been reported in liver nodules in patients with autosomal recessive tyrosinaemia type I addition to mutant keratinocytes in nevoid skin conditions.
caused by fumarylacetoacetate hydrolase (FAH) deficiency (Kvittingen et al., 1994) . The molecular mechaThe reversed allele in the proband was present only in keratinocytes, which derive from ectoderm, whereas nism underlying the reverse mutation remained unresolved, although in some patients it could not be on it was undetectable in leukocytes and fibroblasts, which derive from mesoderm. Furthermore, the bilateral distriaccount of intragenic gene conversion, since the mutation was homozygous. bution of the mosaic suggests that the reverse mutation occurred before lateralization of the embryo was completed. This indicates that the reverse mutation occurred Mitotic Gene Conversion of the Maternal Mutation before the late blastocyst stage in the second week on the COL17A1 Gene Causes Epidermal of development. It is formally possible, however, that Mosaicism in the Compound fibroblast and haematopoietic progenitor cells conHeterozygous Proband tained also the reverse mutation but were not subject Possible mechanisms, other than gene conversion, that to natural selection, since type XVII collagen protein is could account for the observed reverse mutation in our not expressed by these cell types.
proband were excluded or found unlikely (Figure 7 ). DeThe clinical mosaic phenotype with patches of normal letion was excluded by PCR amplification of an exskin suggests that the reverse mutation led to reoccurtended segment of DNA from introns 16 to 19, and by rence of a functional type XVII collagen protein.
It is
Western blot analysis showing type XVII collagen protein well documented for COL17A1 that the presence of a with normal length in revertant keratinocytes. Back mupremature termination codon in both alleles leads to tation (reverse point mutation) was excluded by showing unstable mRNA transcripts and undetectable protein participation of a microsatellite in intron 18 in the reverse levels, similar to the findings in the proband's clinically mutation ( Figure 6 ). Loss of heterozygosity by single affected skin ( Figure 5 , lanes 2 and 5) (Urlaub et al., crossing-over or chromosomal nondisjunction were ex-1989; McGrath et al., 1995) . It is of interest that reversion cluded by showing heterozygosity of flanking polymorof 1706delA/R1226X to WT/R1226X COL17A1 genotype phic markers. Theoretically, double crossing-over might in 50% of the basal cells is sufficient to normalize skin account for the loss of heterozygosity surrounding the function, even if the revertant cells produce lower mutation, but the length of less than 5 cM of the homozyamounts of type XVII collagen protein than the wild-type gous tract makes this unlikely (Smithies and Powers, cells ( Figure 5 ). Somatic gene therapy for certain genes 1986). Moreover, this genetic distance of 5 cM as deterexpressed in the skin might thus be successful if half, mined in meiotic cell divisions (Gyapay et al., 1994) can or perhaps even less, of the basal cell population is be considered as an overestimate of genetic distance reverted.
in mitosis, since recombinational activity in mitosis is lower. Our understanding of the molecular mechanisms Somatic Reversion and Mosaicism Somatic reversion, i.e., reverse mutation during mitosis underlying gene conversion, a metaphor used for any nonreciprocal exchange of homologous genetic inforof a somatic cell, in higher eukaryotes was first encountered in hypothalamic neurons of the Brattleboro rat, mation, is mainly based on studies of meiotic recombination in lower eukaryotes, in which all the products of which has a homozygous frame-shift mutation in the arginine vasopressine gene (AVR), leading to diabetes a single meiosis can be recovered and analyzed. Gene conversion during mitotic recombination is much less insipidus (Van Leeuwen et al., 1989) . Reverse mutation has also been documented in dystrophin-deficient mdx well documented. Because the latter is not possible in mammals in vivo, nonreciprocicity of the genetic exmice (Hoffman et al., 1990) and in humans with Duchenne muscular dystrophy (Klein et al., 1992) . In the change cannot formally be demonstrated. Despite this limitation, the designation "gene conversion" has been latter, the mechanism was demonstrated to be an inframe skipping of the exon containing the mutation applied to exchanges observed in mammalian genomes that involve an alteration of an allele in the range of a (Sherratt et al., 1993) . The Duchenne mosaic phenotype was not clinically recognizable, but only demonstrable few tens to a few thousands of nucleotides at a specific locus in such a way that an internal portion of its seby immunohistochemistry. Back mutation (reverse point mutation), gene conversion, or single or double crossquence has been replaced by a homologous segment copied from another allele or locus (Smithies and Powing-over are more effective than gene deletion (e.g., exon skipping), because with the former the wild-type ers, 1986). In human, gene conversion has been postulated as sequence is completely restored, reestablishing protein function (Figure 7) . an event that may occur during meiosis within several gene families (OMIM, 1996) , and mostly involves inRecently, back mutation has been demonstrated to cause reversion to normal of a deleterious missense tergenic exchange of DNA between pseudogene and gene, leading to forward mutation. The gene conversion mutation on the maternal allele in a patient who was compound heterozygous for autosomal recessive adenobserved in this study apparently occurred during mitosis, was at least in part intragenic, and led to reverse osine deaminase (ADA) deficiency (Hirschhorn et al., 1996) . According to the authors, the patient's condition mutation.
For gene conversion, DNA breaks must occur to make progressively improved, due to the selective growth advantage of the revertant lymphocytes in vivo. Somatic sequence exchange between loci or alleles possible. strand breaks may lead to distinct conversion events (Kourilsky, 1986) . In our proband, a double-strand break gene conversion (Unrau and Johnson, 1995) . Gene con- Giudice et al., 1992) , the following primers were used: sense primer, version plays a major role in controlling the stability 5Ј-TTTCTCTCCTCCCATCACCC-3Ј; antisense primer, 5Ј-CCCTCCC ACTTAAAGGGACA-3Ј. The size of the expected amplification prodof microsatellites in yeast (Gangloff et al., 1996) . It is that reverted the maternal mutation in the coconversion
The size of the expected amplification product was 370 bp. Details of tract.
the polymerase chain reaction (PCR) has been described elsewhere (McGrath et al., 1995) . Following PCR, aliquots of 5 l were examined on a 2% agarose gel electrophoresis.
Experimental Procedures
Heteroduplex analysis was performed by conformation-sensitive gel electrophoresis on polyacrylamide gel (Ganguly et al., 1993) .
Cell Cultures
PCR products demonstrating heteroduplex bands (see Results) Keratinocytes and fibroblasts were cultured from 8 mm punch were purified using a QIAquick PCR purification kit (Qiagen) and biopsies from clinically unaffected skin and from perilesional skin sequenced directly by an automated nucleotide sequencer (ABI) of the proband. Epidermis was separated from the dermis after with the same primers as were used for initial PCR amplification. incubation with 0.03% trypsin, 0.01% EDTA. The harvested keratinocytes were cultured under serum-free conditions using keratinocyte Verification of Mutations growth medium (Clonetics, Inc.) according to Mitra and Nickoloff For verification of the paternal mutation, 3781 C-to-T, which resulted (1994) .
in the loss of a TaqI site (TCGA), the PCR product (10 l) was subjected to enzyme digestion (New England Biolabs). The digestion Immunofluorescence Microscopy and Electron Microscopy products were electrophoresed on a 3.5% agarose gel. For verificaSnap frozen biopsies were taken from clinically unaffected skin tion of the maternal mutation, oligonucleotide probes covering the (forearm) and from normal looking affected skin (forearm, upper sites of the mutation within exon 18 were designed for allele-specific arm, and abdomen) of the proband. Skin biopsies were also taken oligonucleotide (ASO) hybridization of the PCR products spanning from the upper arm of the parents. Monoclonal IgG1 antibodies 1D1 the mutation. A standard protocol was used (Christiano et al., 1994) . and 1A8c were directed against the extracellular and intracellular
The probes were as follows: wild-type, 5Ј-GCGGGAGCAGACCTGG domains of type XVII collagen, respectively (Owaribe et al., 1991;  ACAA-3Ј; mutated allele, 5Ј-GCGGGAGCAGCCTGGACAAA-3Ј. . The immunofluorescence staining procedures for dual detection of type XVII collagen (moab 1D1) and inteHaplotype Analysis grin ␤4 subunit (moab 439-9B, gift from Dr. S. J. Kennell) have been To detect possible crossing-over, the alleles flanking the COL17A1 detailed elsewhere (Jonkman et al., 1995) . For immunofluorescence gene on chromosome 10q24.3 were analyzed using microsatellite microscopy of cultured keratinocytes, cells were fixed with 1% formpolymorphisms (Gyapay et al., 1994) . The following flanking markers aldehyde, permeabilized with 0.5% Triton X-100, and incubated subwere used: D10S603 -3-D10S566 -5-[D10S597, D10S554] -6-sequently with 1A8c, fluorescein isothiocyanate-conjugated (FITC) D10S562 -3-D10S542. Genetic distances in centimorgans are indigoat anti-mouse IgG monoclonal antibody (Becton Dickinson, San cated between the markers. The intragenic COL17A1 microsatellite Jose, CA), and FITC-rabbit anti-goat IgG monoclonal antibody (Dako (COL17A1-CA1) in intron 18 (position 1792ϩ295) (Figure 6 , middle) A/S, Glostrup, Denmark). Bizbenzimide was used as blue nuclear was amplified as described elsewhere (H. S. et al., submitted). The stain. For electron microscopy, routine procedures were followed primers used for COL17A1-CA1 were: sense primer, 5Ј-CAGGAAAA as previously described (Jonkman et al., 1992) .
TGGTGGTGAGAGC-3Ј; antisense primer 5Ј-TCGGAGATTTCCTGCA AGT-3Ј.
Isolation of Type XVII Collagen-Positive Keratinocytes
One base pair polymorphisms in the COL17A1 gene were deFrozen pellets of previously trypsinized cells were resuspended in tected by direct sequencing and, if possible, confirmed by restriction ice-cold PBS. The cells were fixed with 1% paraformaldehyde and endonuclease digestion with the same method as described by permeabilized with 0.3% saponin. 1A8c was chosen as primary verification of the mutation. The polymorphisms examined were in antibody, since it recognizes the endodomain of type XVII collagen exon 10, 734 T/C (BsrD I); exon 14, 1168 T/C (DdeI); intron 19, that remains intact after trypsinization. FITC labeling was achieved 1822ϩ14 T/C; exon 27, 2212 A/G; intron 28, 2268ϩ120 T/C (NlaIV); as described above. Cells were sorted on a Coulter Epics-Elite exon 37, 2700 T/C (BstU I); and in exon 43, 2988 A/C (EcoO109 I) equipped with a 15 mW 488 Argon laser. With the use of a conjugate (Gatalica et al., 1997) . staining (omitting the primary antibody), the nonspecific staining To rule out gene deletion, we amplified a 1892 bp product surwas estimated, which was then used to define the positive popurounding the maternal mutation (exon 18) from intron 16 (1373-64) lation.
to intron 19 (1822ϩ116) using the following primers: sense primer, 5Ј-GAGAATCTGGAGGGAAAAGG-3Ј; antisense primer, 5-ЈAGTCAT TCAGCTCTTCATCC-3Ј. Western Blot For Western blot, extracts of cultured keratinocytes of proband's In order to estimate the maximal length of the conversion tract, introns 3 to 17 of COL17A1 gene were amplified, using primers unaffected and affected skin were used. SDS-polyacrylamide gel electrophoresis and blotting were performed as described before based on the flanking exonic sequences (Gatalica et al., 1997) . PCR products were sequenced by an automated nucleotide sequencer (Pas et al., 1995) . The primary antibodies used were moab 1A8c and serum IgG from a patient with bullous pemphigoid. Bound anti-(ALF, Pharmacia) with the same primers as were used for initial PCR amplification. bodies were detected by subsequent incubation with either goat
